6877 — Top Eminent Healthcare Cashflow Statement
0.000.00%
Last trade - 00:00- HK$319.23m
- HK$101.79m
- HK$86.49m
Annual cashflow statement for Top Eminent Healthcare, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -81.2 | -57.9 | -31 | 14.6 | 12.6 |
| Depreciation | |||||
| Non-Cash Items | -0.952 | -0.928 | -1.8 | -12.6 | -8.86 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 61.4 | 7.94 | 13.4 | -0.582 | -23.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -5.87 | -39.3 | -16.8 | 1.82 | -19.9 |
| Capital Expenditures | -0.628 | -0.86 | -0.003 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1.95 | 3.08 | 1.78 | 9.64 | 9.48 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.58 | 2.21 | 1.78 | 9.64 | 9.48 |
| Financing Cash Flow Items | -0.593 | -0.288 | -0.209 | -0.001 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -12.3 | -10.1 | -2.12 | -0.001 | 0 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -8.44 | -52.6 | -22.7 | 10.6 | -17.2 |